标题
Breast cancer intratumour heterogeneity: current status and clinical implications
作者
关键词
-
出版物
HISTOPATHOLOGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2018-05-03
DOI
10.1111/his.13642
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Analytical Validation of the Next-Generation Sequencing Assay for a Nationwide Signal-Finding Clinical Trial
- (2017) Chih-Jian Lih et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Intra-tumor heterogeneity from a cancer stem cell perspective
- (2017) Pramudita R. Prasetyanti et al. Molecular Cancer
- Towards Precision Medicine in the Clinic: From Biomarker Discovery to Novel Therapeutics
- (2017) Dearbhaile C. Collins et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Validation of multiplex immunofluorescence panels using multispectral microscopy for immune-profiling of formalin-fixed and paraffin-embedded human tumor tissues
- (2017) Edwin R. Parra et al. Scientific Reports
- Next-generation sequencing of BRCA1/2 in breast cancer patients: potential effects on clinical decision-making using rapid, high-accuracy genetic results
- (2017) Hyung Seok Park et al. Annals of Surgical Treatment and Research
- Mechanisms and Consequences of Cancer Genome Instability: Lessons from Genome Sequencing Studies
- (2016) June-Koo Lee et al. Annual Review of Pathology-Mechanisms of Disease
- Multiplexed imaging reveals heterogeneity of PI3K/MAPK network signaling in breast lesions of known PIK3CA genotype
- (2016) Thomas Jacob et al. BREAST CANCER RESEARCH AND TREATMENT
- Further evidence to support bimodality of oestrogen receptor expression in breast cancer
- (2016) Abir A Muftah et al. HISTOPATHOLOGY
- Molecular Imaging of Biomarkers in Breast Cancer
- (2016) G. A. Ulaner et al. JOURNAL OF NUCLEAR MEDICINE
- Punctuated copy number evolution and clonal stasis in triple-negative breast cancer
- (2016) Ruli Gao et al. NATURE GENETICS
- Image-based computational quantification and visualization of genetic alterations and tumour heterogeneity
- (2016) Qing Zhong et al. Scientific Reports
- Biological and Therapeutic Impact of Intratumor Heterogeneity in Cancer Evolution
- (2015) Nicholas McGranahan et al. CANCER CELL
- Morphogenesis of the papillary lesions of the breast: phenotypic observation
- (2015) Emad A Rakha JOURNAL OF CLINICAL PATHOLOGY
- Breast Tumor Heterogeneity: Source of Fitness, Hurdle for Therapy
- (2015) Shany Koren et al. MOLECULAR CELL
- Subclonal diversification of primary breast cancer revealed by multiregion sequencing
- (2015) Lucy R Yates et al. NATURE MEDICINE
- Clinical management of breast cancer heterogeneity
- (2015) Dimitrios Zardavas et al. Nature Reviews Clinical Oncology
- Exome Sequencing of Cell-Free DNA from Metastatic Cancer Patients Identifies Clinically Actionable Mutations Distinct from Primary Disease
- (2015) Timothy M. Butler et al. PLoS One
- Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer
- (2015) Gaia Schiavon et al. Science Translational Medicine
- Intratumoral genome diversity parallels progression and predicts outcome in pediatric cancer
- (2015) Linda Holmquist Mengelbier et al. Nature Communications
- Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer
- (2015) Muhammed Murtaza et al. Nature Communications
- The IL-6/JAK/Stat3 Feed-Forward Loop Drives Tumorigenesis and Metastasis
- (2015) Qing Chang et al. NEOPLASIA
- HER2 Heterogeneity Affects Trastuzumab Responses and Survival in Patients With HER2-Positive Metastatic Breast Cancer
- (2014) Hee Jin Lee et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
- (2014) R. Salgado et al. ANNALS OF ONCOLOGY
- Biopsy confirmation of metastatic sites in breast cancer patients: clinical impact and future perspectives
- (2014) Carmen Criscitiello et al. BREAST CANCER RESEARCH
- The role of texture analysis in imaging as an outcome predictor and potential tool in radiotherapy treatment planning
- (2014) S Alobaidli et al. BRITISH JOURNAL OF RADIOLOGY
- Genetic and Phenotypic Diversity in Breast Tumor Metastases
- (2014) V. Almendro et al. CANCER RESEARCH
- Development of Circulating Tumor Cell-Endocrine Therapy Index in Patients with Hormone Receptor–Positive Breast Cancer
- (2014) Costanza Paoletti et al. CLINICAL CANCER RESEARCH
- Circulating Tumor DNA as a Liquid Biopsy for Cancer
- (2014) E. Heitzer et al. CLINICAL CHEMISTRY
- Patients' perception of information after completion of adjuvant radiotherapy for breast cancer
- (2014) Mia Bergenmar et al. European Journal of Oncology Nursing
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199
- (2014) Sylvia Adams et al. JOURNAL OF CLINICAL ONCOLOGY
- Updated UK Recommendations for HER2 assessment in breast cancer
- (2014) Emad A Rakha et al. JOURNAL OF CLINICAL PATHOLOGY
- Quantitative measurement of cancer tissue biomarkers in the lab and in the clinic
- (2014) Daniel E Carvajal-Hausdorf et al. LABORATORY INVESTIGATION
- Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data
- (2014) François-Clément Bidard et al. LANCET ONCOLOGY
- Tumor signatures in the blood
- (2014) Michael R Speicher et al. NATURE BIOTECHNOLOGY
- Discordant hormone receptor and human epidermal growth factor receptor 2 status in bone metastases compared to primary breast cancer
- (2013) Gaetano Aurilio et al. ACTA ONCOLOGICA
- The molecular diversity of Luminal A breast tumors
- (2013) Giovanni Ciriello et al. BREAST CANCER RESEARCH AND TREATMENT
- The detection and implication of genome instability in cancer
- (2013) Larissa Pikor et al. CANCER AND METASTASIS REVIEWS
- Towards a personalized breast cancer treatment approach guided by circulating tumor cell (CTC) characteristics
- (2013) W. Onstenk et al. CANCER TREATMENT REVIEWS
- Evolution and Impact of Subclonal Mutations in Chronic Lymphocytic Leukemia
- (2013) Dan A. Landau et al. CELL
- A new genome-driven integrated classification of breast cancer and its implications
- (2013) Sarah-Jane Dawson et al. EMBO JOURNAL
- Guidelines and considerations for conducting experiments using tissue microarrays
- (2013) Mohammad Ilyas et al. HISTOPATHOLOGY
- Influence of tumour micro-environment heterogeneity on therapeutic response
- (2013) Melissa R. Junttila et al. NATURE
- Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA
- (2013) Muhammed Murtaza et al. NATURE
- Cancer genome-sequencing study design
- (2013) Jill C. Mwenifumbo et al. NATURE REVIEWS GENETICS
- Highly multiplexed single-cell analysis of formalin-fixed, paraffin-embedded cancer tissue
- (2013) M. J. Gerdes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cancer Genome Landscapes
- (2013) B. Vogelstein et al. SCIENCE
- A critical review why assessment of steroid hormone receptors in breast cancer should be quantitative
- (2012) O. Brouckaert et al. ANNALS OF ONCOLOGY
- P3-05-10: Standardized Quantitative Methods for Investigating the Intratumor Heterogeneity of HER2 in FFPE Breast Cancer Specimens Utilizing the Vectra System, inForm and AQUA Technology.
- (2012) CC Hoyt et al. CANCER RESEARCH
- Mutational Processes Molding the Genomes of 21 Breast Cancers
- (2012) Serena Nik-Zainal et al. CELL
- The Life History of 21 Breast Cancers
- (2012) Serena Nik-Zainal et al. CELL
- Circulating Tumor Cells: Liquid Biopsy of Cancer
- (2012) C. Alix-Panabieres et al. CLINICAL CHEMISTRY
- Next-generation sequencing in breast cancer
- (2012) Christine Desmedt et al. CURRENT OPINION IN ONCOLOGY
- Cancer chromosomal instability: therapeutic and diagnostic challenges
- (2012) Nicholas McGranahan et al. EMBO REPORTS
- Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression
- (2012) Linda Sofie Lindström et al. JOURNAL OF CLINICAL ONCOLOGY
- Intratumoral heterogeneity of HER2 gene amplification in breast cancer: its clinicopathological significance
- (2012) Hyesil Seol et al. MODERN PATHOLOGY
- The landscape of cancer genes and mutational processes in breast cancer
- (2012) Philip J. Stephens et al. NATURE
- The clonal and mutational evolution spectrum of primary triple-negative breast cancers
- (2012) Sohrab P. Shah et al. NATURE
- DNA breaks and chromosome pulverization from errors in mitosis
- (2012) Karen Crasta et al. NATURE
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
- (2012) Christina Curtis et al. NATURE
- Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
- (2012) Marco Gerlinger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Quantification of intra-tumour cell proliferation heterogeneity using imaging descriptors of 18F fluorothymidine-positron emission tomography
- (2012) J M Y Willaime et al. PHYSICS IN MEDICINE AND BIOLOGY
- Noninvasive Identification and Monitoring of Cancer Mutations by Targeted Deep Sequencing of Plasma DNA
- (2012) T. Forshew et al. Science Translational Medicine
- Frequency of HER2 Heterogeneity by Fluorescence In Situ Hybridization According to CAP Expert Panel Recommendations
- (2011) Kimberly H. Allison et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- The prognostic significance of B lymphocytes in invasive carcinoma of the breast
- (2011) S. M. A. Mahmoud et al. BREAST CANCER RESEARCH AND TREATMENT
- Relationship of Extreme Chromosomal Instability with Long-term Survival in a Retrospective Analysis of Primary Breast Cancer
- (2011) R. Roylance et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- HER2-amplified breast cancer: mechanisms of trastuzumab resistance and novel targeted therapies
- (2011) Devika Gajria et al. Expert Review of Anticancer Therapy
- Heterogeneity in breast cancer
- (2011) Kornelia Polyak JOURNAL OF CLINICAL INVESTIGATION
- Insight into the heterogeneity of breast cancer through next-generation sequencing
- (2011) Hege G. Russnes et al. JOURNAL OF CLINICAL INVESTIGATION
- Secondary Somatic Mutations Restoring BRCA1/2 Predict Chemotherapy Resistance in Hereditary Ovarian Carcinomas
- (2011) Barbara Norquist et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer
- (2011) Sahar M.A. Mahmoud et al. JOURNAL OF CLINICAL ONCOLOGY
- Loss of Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Metastatic Sites of HER2-Overexpressing Primary Breast Tumors
- (2011) Naoki Niikura et al. JOURNAL OF CLINICAL ONCOLOGY
- Prospective Study Evaluating the Impact of Tissue Confirmation of Metastatic Disease in Patients With Breast Cancer
- (2011) Eitan Amir et al. JOURNAL OF CLINICAL ONCOLOGY
- Direct evidence for concurrent morphological and genetic heterogeneity in an invasive ductal carcinoma of triple-negative phenotype
- (2011) N. Patani et al. JOURNAL OF CLINICAL PATHOLOGY
- Tumour evolution inferred by single-cell sequencing
- (2011) Nicholas Navin et al. NATURE
- Mutational Inactivation of STAG2 Causes Aneuploidy in Human Cancer
- (2011) D. A. Solomon et al. SCIENCE
- Hormone Receptor and c-ERBB2 Status in Distant Metastatic and Locally Recurrent Breast Cancer
- (2010) Pushpalatha K.A. Idirisinghe et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Patterns and incidence of chromosomal instability and their prognostic relevance in breast cancer subtypes
- (2010) Marcel Smid et al. BREAST CANCER RESEARCH AND TREATMENT
- An evaluation of the clinical significance of FOXP3+ infiltrating cells in human breast cancer
- (2010) Sahar M. A. Mahmoud et al. BREAST CANCER RESEARCH AND TREATMENT
- Quantitative HER2 protein levels predict outcome in fluorescence in situ hybridization-positive patients with metastatic breast cancer treated with trastuzumab
- (2010) Allan Lipton et al. CANCER
- Genomic differences between estrogen receptor (ER)-positive and ER-negative human breast carcinoma identified by single nucleotide polymorphism array comparative genome hybridization analysis
- (2010) Min Fang et al. CANCER
- Breast core needle biopsy: issues and controversies
- (2010) Michael Bilous MODERN PATHOLOGY
- Genome remodelling in a basal-like breast cancer metastasis and xenograft
- (2010) Li Ding et al. NATURE
- Gene-expression-based prognostic assays for breast cancer
- (2010) Chungyeul Kim et al. Nature Reviews Clinical Oncology
- Advances in understanding cancer genomes through second-generation sequencing
- (2010) Matthew Meyerson et al. NATURE REVIEWS GENETICS
- Telomeres: protecting chromosomes against genome instability
- (2010) Roderick J. O'Sullivan et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Individual genomes and personalized medicine: life diversity and complexity
- (2010) Christos Katsios et al. Personalized Medicine
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
- (2010) M. Elizabeth H. Hammond et al. Journal of Oncology Practice
- Significance of breast lesion descriptors in the ACR BI-RADS MRI lexicon
- (2009) Garima Agrawal et al. CANCER
- A Novel Proximity Assay for the Detection of Proteins and Protein Complexes: Quantitation of HER1 and HER2 Total Protein Expression and Homodimerization in Formalin-fixed, Paraffin-Embedded Cell Lines and Breast Cancer Tissue
- (2009) Yining Shi et al. DIAGNOSTIC MOLECULAR PATHOLOGY
- Inferring tumor progression from genomic heterogeneity
- (2009) N. Navin et al. GENOME RESEARCH
- Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution
- (2009) Sohrab P. Shah et al. NATURE
- Somatic mutations affect key pathways in lung adenocarcinoma
- (2008) Li Ding et al. NATURE
- Resistance to therapy caused by intragenic deletion in BRCA2
- (2008) Stacey L. Edwards et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started